ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,055Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 403

$638K Total Retail Price of All Prescriptions

Rank: 22 out of 403

216 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 216 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 216 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 5,276 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 304 246 1 4
LEVOTHYROXINE SODIUM 266 169 2 3
LISINOPRIL 193 93 3 1
NEXIUM 185 116 4 18
SIMVASTATIN 176 114 5 2
METFORMIN HCL 175 69 6 8
FUROSEMIDE 171 134 7 7
ATORVASTATIN CALCIUM 161 93 8 5
CARVEDILOL 160 110 9 32
CRESTOR 154 105 10 19
OMEPRAZOLE 144 88 11 9
GABAPENTIN 140 84 12 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 82 13 29
LOVASTATIN 128 96 14 42
ZOLPIDEM TARTRATE 114 99 15 16
ATENOLOL 107 69 16 13
TAMSULOSIN HCL 106 34 17 27
ALENDRONATE SODIUM 105 82 18 26
HYDROCHLOROTHIAZIDE 104 66 19 6
TRAMADOL HCL 98 60 20 28
GLYBURIDE-METFORMIN HCL 92 69 R 21 161
METOPROLOL SUCCINATE 91 63 22 11
SERTRALINE HCL 91 64 22 20
MELOXICAM 91 61 22 58
ROPINIROLE HCL 91 59 22 123
LOSARTAN POTASSIUM 89 75 26 21
ZETIA 86 62 27 59
PROAIR HFA 82 49 28 40
CYCLOBENZAPRINE HCL 81 0 R 29 91
MIRTAZAPINE 81 0 29 38
PREDNISONE 78 58 31 34
ADVAIR DISKUS 76 19 32 33
HYDROCODONE-ACETAMINOPHEN 74 62 S3 33 15
DEXILANT 74 38 33 81
ALLOPURINOL 71 46 35 31
PEN NEEDLE 71 53 35 137
RISPERIDONE 65 0 37 48
ACTOS 63 63 38 95
SPIRIVA 62 0 39 35
VESICARE 61 36 40 200
LANTUS SOLOSTAR 60 44 41 80
PAROXETINE HCL 60 25 41 68
LIPITOR 60 45 41 53
DIVALPROEX SODIUM 59 0 44 64
VENLAFAXINE HCL ER 58 39 45 95
AMITIZA 57 38 46 128
OLANZAPINE 56 12 47 77
FLUOXETINE HCL 55 0 48 57
DICLOFENAC SODIUM 54 21 49 205
GLIMEPIRIDE 53 47 50 61
CITALOPRAM HBR 52 50 51 22
METOPROLOL TARTRATE 51 38 52 10
LYRICA 50 34 53 116
MECLIZINE HCL 50 0 53 141
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.